comparemela.com
Home
Live Updates
Head Of The German Hodgkin Study Group - Breaking News
Pages:
Latest Breaking News On - Head of the german hodgkin study group - Page 1 : comparemela.com
Phase 3 Trial of ADCETRIS® (brentuximab vedotin) with Modified Chemo Regimen Shows Non-Inferiority with Unprecedented 3-Year Progression Free Survival of 94 9% vs Less Tolerable International Standard of Care in Advanced Classical Hodgkin Lymphoma
– Results are from 1,500 patient trial conducted by German Hodgkin Study Group to test ADCETRIS regimen versus international standard eBEACOPP therapy – ADCETRIS regimen showed less. | June 20, 2023
District of columbia
United states
Peter borchmann
Roger dansey
Head of the lymphoma program
University hospital of cologne
International agency for research on cancer
Head of the german hodgkin study group
International conference on malignant lymphoma
American society of hematology
Department of internal medicine
German hodgkin study group
Seagen inc
Department of hematology
Trial coordination center
University of cologne
vimarsana © 2020. All Rights Reserved.